Please see the attached file containing information on a funding opportunity entitled “Innovations for Gram-Negative Antibiotic Discovery,”  a unique collaboration among three partners, the Novo Nordisk Foundation, Wellcome, and the Bill & Melinda Gates Foundation.

Through this GC RFP, the partners are launching a new initiative, the Gram-Negative Antibiotic Discovery Innovator (Gr-ADI). Gr-ADI will bring together funders, research institutions, and industry partners to address the problem of antimicrobial resistance, now the third leading cause of death globally.

The deadline of submission is on 25 March 2025.

More info in this link: https://gcgh.grandchallenges.org/challenge/innovations-gram-negative-antibiotic-discovery